2016 - IPITA - Stem Cell Derived Beta Cells Workshop

This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Monitoring and Modulating immune responses

8.2 - Assessment of adaptive immune responses to hESC-derived progenitors and endocrine cells

Presenter: Bart, Roep, Leiden, Netherlands
Authors: Bart Roep

Human embryonic stem cells (hESC) have great potential to provide an unlimited alternative source of beta-cells to overcome the donor shortage in islet transplantation to treat advanced type 1 diabetes. Given hESC may have immune privileged properties, it is important to determine if these properties are preserved in hESC-derived cells. We investigated immunological properties of hESC-derived pancreatic progenitor cells, and further in vivo differentiated hESC-derived endocrine cells by assessing HLA and complement receptor expression and exposure to alloreactive antibodies and cytotoxic T-cells and autoimmune cytotoxic T-cells. hESC-derived pancreatic endoderm expresses relatively low levels of HLA endorsing protection from specific immune responses. HLA was upregulated when exposed to interferon gamma (IFNγ), making these endocrine progenitor cells vulnerable to cytotoxic T-cells and alloreactive antibodies. In vivo differentiated endocrine cells were protected from complement, but expressed more HLA and were targets for alloreactive antibody-dependent cellular cytotoxicity and alloreactive cytotoxic T-cells. After HLA compatibility was provided by transduction with HLA-A2, preproinsulin specific T-cells killed insulin producing cells. Thus, hESC-derived pancreatic progenitors are hypoimmunogenic, while in vivo differentiated endocrine cells represent mature targets to adaptive immune responses. Our data support the need for immune intervention in transplantation of hESC-derived pancreatic progenitors. Cell-impermeable macro-encapsulation may suffice.

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6